secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001493152-23-046572
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma raises CSO and CFO salaries and bonus targets effective Jan 1, 2024
--------------------------------------------------------------------------------

- CSO Kishor Bhatia base salary increased to $316,000; target bonus set at 40% of base.
- CFO David Margrave base salary increased to $413,800; target bonus set at 40% of base.
- Changes effective January 1, 2024, based on independent compensation advisory firm analysis.
- Amendments to employment agreements approved by Compensation Committee and Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/0001493152-23-046572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223046572/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-046572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer